Artículos (21) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus

    Journal of Pharmacy and Pharmacology, Vol. 57, Núm. 3, pp. 317-325

  2. Aminopeptidase activity in the postmortem brain of human heroin addicts

    Neurochemistry International, Vol. 46, Núm. 3, pp. 213-219

  3. Bicompartmental kinetics of tobramycin analysed with a wide range of covariates

    International Journal of Antimicrobial Agents, Vol. 26, Núm. 4, pp. 304-311

  4. Buprenorfina en dependencia a opiáceos: Reflexiones sobra la seguridad

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 7, Núm. 1, pp. 27-30

  5. Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis

    Psychopharmacology, Vol. 180, Núm. 3, pp. 570-579

  6. Environmental tobacco smoke exposure in public places of European cities

    Tobacco Control, Vol. 14, Núm. 1, pp. 60-63

  7. Evaluation of a pharmacology educational activity based on a research project: A randomized, controlled and blind analysis of medical students' perceptions

    Medical Teacher, Vol. 27, Núm. 1, pp. 53-60

  8. Gene symbol: MECP2. Disease: Rett syndrome (atypical).

    Human genetics, Vol. 118, Núm. 3-4, pp. 547

  9. Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats

    Synapse, Vol. 57, Núm. 1, pp. 38-46

  10. Neuroprotective effect of L-arginine in a newborn rat model of acute severe asphyxia

    Biology of the Neonate, Vol. 88, Núm. 4, pp. 291-298

  11. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

    Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563

  12. Opposite changes in Imidazoline I2 receptors and α2-adrenoceptors density in rat frontal cortex after induced gliosis

    Life Sciences, Vol. 78, Núm. 2, pp. 205-209

  13. Papel de los receptores de serotonina 5-HT3 localizados en el locus coeruleus sobre la modulación del sistema noradrenérgico: XXVII Congreso nacional de la SEF

    Actualidad en farmacología y terapéutica, Vol. 3, Núm. 4, pp. 295-296

  14. Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: An integrated parent-metabolite model

    Pharmaceutical Research, Vol. 22, Núm. 11, pp. 1769-1782

  15. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties

    Psychopharmacology, Vol. 182, Núm. 3, pp. 400-413

  16. Repercusión de la modulación de la P-glicoproteína en la cinética de fármacos sustratos: influencia de la vía de administración: XXVII Congreso nacional de la SEF

    Actualidad en farmacología y terapéutica, Vol. 3, Núm. 4, pp. 297-298

  17. Subcellular distribution of membrane-bound aminopeptidases in the human and rat brain

    Neuroscience Letters, Vol. 383, Núm. 1-2, pp. 136-140

  18. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain

    Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626

  19. Time-dependent pharmacokinetics of cyclosporine (Neoral®) in de novo renal transplant patients

    Journal of Clinical Pharmacy and Therapeutics, Vol. 30, Núm. 6, pp. 549-557

  20. α2-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons

    European Journal of Pharmacology, Vol. 517, Núm. 1-2, pp. 51-58